Last reviewed · How we verify
NCT06779201
Fasting Effects on Metabolism and Immunity Study in Human
NA trial testing Fasting in Fasting in 30 participants. Currently enrolling.
31 October 2027
Quick facts
| Lead sponsor | Xuanwu Hospital, Beijing |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 1 September 2024 |
| Primary completion | 31 October 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Fasting
Conditions studied
- Fasting — all drugs for Fasting →
Sponsor
Xuanwu Hospital, Beijing
Who can join
Adults 18 to 65, any sex, with Fasting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effects of 1-week fasting but not prohibiting water drink on human immune function, metabolic indicators, and brain function in human, and to explore the underlying mechanisms of these changes from a multi-omics perspective and/or other ways.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06779201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fasting
Trials testing the same drug.
- NCT07216989 — Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting · recruiting
- NCT06826924 — 7-Days Water-Only Fasting Trial in Prostate Cancer · NA · recruiting
- NCT07009288 — A Study of Time-Restricted Eating in Childhood Cancer Survivors · NA · recruiting
- NCT06963437 — Interventions for Weight Regain After Bariatric Surgery · NA · completed
- NCT07178106 — Investigation of the Relationship Between Peripheral and Central Metabolic Changes Caused by Fasting · NA · completed
Other recruiting trials for Fasting
Currently open trials in the same condition.
- NCT07216989 — Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting · recruiting
- NCT06737224 — The Impact of a 48-hour Fast with or Without Exercise on Immune Cell Metabolism and Glycemic Control in Healthy Active A · NA · recruiting
- NCT06420739 — The Semaglutide Study · active not recruiting
- NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting
- NCT06134258 — Mechanisms of Fasting Induced Reduction in Energy Expenditure · NA · recruiting
Other Xuanwu Hospital, Beijing trials
Trials by the same sponsor.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07519044 — Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion · Phase 4 · not yet recruiting
- NCT07396077 — Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II · NA · not yet recruiting
- NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease · Phase 1, PHASE2 · not yet recruiting
- NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06779201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xuanwu Hospital, Beijing
- Last refreshed: 22 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06779201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing